Category Archives: Cancer and neoplasms

Integration challenges with tuberculosis patients care

Introduction Tuberculosis disease (TB) is a major public health problem and the top list of causes of death in the world.1 From 95% of tuberculosis deaths occurred in low-middle-income countries (LMICs), two-thirds of deaths happened in 8 LMICs and Ethiopia is one of the top 22 counties affected by tuberculosis (TB)2 with a 2.1/1000 incidence […]

NGeneBio’s blood cancer diagnostic panel gets permit in Thailand

NgeneBio, a Kosdaq-listed biotech firm, said Tuesday that it has obtained marketing authorization for Hemeaccutest, a blood cancer precision diagnostic panel based on next-generation sequencing (NGS) technology, from the Thai Food and Drug Administration (TFDA). (Credit: NGeneBio) Hemeaccutest, utilizing NGS, can identify mutations in over 100 genes associated with various hematological malignancies, such as myelodysplastic syndromes […]

FDA Approves Nirogacestat for Treatment of Desmoid Tumors

SpringWorks Therapeutics announced late today that the FDA has approved nirogacestat, which the company says is the first therapy available to treat adult patients with progressing desmoid tumors who require systemic treatment. The therapy, an oral gama secretase inhibitor, will be marketed as Ogsiveo, the company announced in a statement. The FDA previously granted breakthrough […]

Immunotherapy for Nasopharyngeal Carcinoma

Original Investigation Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma Hai-Qiang Mai, MD, PhD; Qiu-Yan Chen, MD, PhD; Dongping Chen, MD; Chaosu Hu, PhD; Kunyu Yang, MD, PhD; Jiyu Wen, BS; Jingao Li, MD, PhD; Yingrui Shi, PhD; Feng Jin, MD; Ruilian Xu, MD; Jianji Pan, PhD; Shenhong Qu, MD; Ping Li, MD, PhD; Chunhong Hu, PhD; Yi-Chun Liu, MD; Yi Jiang, MD; Xia He, MD, PhD; Hung-Ming Wang, MD; Wan-Teck Lim, MBBS; Wangjun Liao, MD, PhD; Xiaohui He, MD; Xiaozhong Chen, MD; Siyang Wang, PhD; Xianglin Yuan, MD; Qi Li, PhD; Xiaoyan Lin, PhD; Shanghua Jing, MD; Yanju Chen, MD; Yin Lu, MD; Ching-Yun Hsieh, MD; Muh-Hwa Yang, MD, PhD; Chia-Jui Yen, MD, PhD; Jens Samol, MD; Xianming Luo, MD; Xiaojun Wang, MS; […]

Yale Cancer Center Experts Present New Research at Hematology Annual Meeting

Newswise — Physicians and scientists from Yale Cancer Center, part of Yale School of Medicine, will present new research at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, Calif., from December 9 to 12. This year’s ASH meeting will include oral and poster presentations, workshops, and educational sessions for […]

As deaths due to work-related factors increase, ILO report calls for countries to strengthen safety net

Nearly 30 lakh workers die every year globally due to work-related accidents and diseases, according to a new report prepared by the International Labour Organization (ILO). More than 63% of these deaths are reported from the Asia-Pacific region. Exposure to long working hours (55 hours or more per week) was the biggest “killer”, with almost […]

PRO-TECT Trial Shows That ePROs May Be Feasibly Implemented Into Routine Oncology Practice

Ethan Basch, MD, MSc Leveraging electronic patient-reported outcomes (ePROs) may be a feasible, alternative approach to symptom monitoring in cancer care, according to findings from the PRO-TECT trial (NCT03249090), which were presented at the 2023 European Society of Medical Oncology Congress. Key Findings On average, the rate of weekly ePRO completion was 91.5%. This high […]

Study Results Demonstrate Early Potential of Breast Cancer Treatment With Minimal Adverse Effects

A series of experiments with the narrow-spectrum Wnt signaling inhibitor TcdBFBD were conducted in several mouse models mimicking different types of breast cancer, such as basal-like and luminal-like, that are found in humans. TcdBFBD is derived from a toxin found naturally in Clostridium difficile (C. diff).1 Image credit: romaset | stock.adobe.com Although certain subtypes of […]